These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10861485)

  • 21. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
    Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.
    Bello L; Lucini V; Giussani C; Carrabba G; Pluderi M; Scaglione F; Tomei G; Villani R; Black PM; Bikfalvi A; Carroll RS
    Neurosurgery; 2003 Jan; 52(1):177-85; discussion 185-6. PubMed ID: 12493116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenic activity of endostatin inhibits C6 glioma growth.
    Peroulis I; Jonas N; Saleh M
    Int J Cancer; 2002 Feb; 97(6):839-45. PubMed ID: 11857365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.
    Litz J; Sakuntala Warshamana-Greene G; Sulanke G; Lipson KE; Krystal GW
    Lung Cancer; 2004 Dec; 46(3):283-91. PubMed ID: 15541812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
    Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
    Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
    Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
    Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flk-1 specific kinase inhibitor (SU5416) inhibited the growth of GS-9L glioma in rat brain and prolonged the survival.
    Takamoto T; Sasaki M; Kuno T; Tamaki N
    Kobe J Med Sci; 2001 Aug; 47(4):181-91. PubMed ID: 11733657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
    Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
    Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma.
    Auf G; Jabouille A; Guérit S; Pineau R; Delugin M; Bouchecareilh M; Magnin N; Favereaux A; Maitre M; Gaiser T; von Deimling A; Czabanka M; Vajkoczy P; Chevet E; Bikfalvi A; Moenner M
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15553-8. PubMed ID: 20702765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of VEGF-R2 inhibition on MMP secretion and motility of microvascular human cerebral endothelial cells (HCEC).
    Wagner S; Fueller T; Hummel V; Rieckmann P; Tonn JC
    J Neurooncol; 2003 May; 62(3):221-31. PubMed ID: 12777073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging.
    Goldbrunner RH; Bendszus M; Sasaki M; Kraemer T; Plate KH; Roosen K; Tonn JC
    Neurosurgery; 2000 Oct; 47(4):921-9; discussion 929-30. PubMed ID: 11014432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse.
    Vajkoczy P; Schilling L; Ullrich A; Schmiedek P; Menger MD
    J Cereb Blood Flow Metab; 1998 May; 18(5):510-20. PubMed ID: 9591843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.
    Yunker CK; Golembieski W; Lemke N; Schultz CR; Cazacu S; Brodie C; Rempel SA
    Int J Cancer; 2008 Jun; 122(12):2735-43. PubMed ID: 18350569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas.
    Li Y; Fu SY; Wang LH; Wang FY; Wang NN; Cao Q; Wang YT; Yang JY; Wu CF
    Cancer Lett; 2015 Dec; 369(1):86-96. PubMed ID: 26254539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
    Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
    Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide.
    Zhou Q; Guo P; Gallo JM
    Clin Cancer Res; 2008 Mar; 14(5):1540-9. PubMed ID: 18316579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.